United States v. Dorothy R. Garber

607 F.2d 92, 44 A.F.T.R.2d (RIA) 6095, 1979 U.S. App. LEXIS 10349
Court of Appeals for the Fifth Circuit·Decided November 19, 1979·No. 78-5024·Published·Cited by 93 cases

Opinions

CHARLES CLARK, Circuit Judge:

Dorothy Clark Garber was indicted for willfully and knowingly attempting to evade a portion of her income tax liability for the years 1970, 1971, and 1972 by filing a false and fraudulent income tax return on behalf of herself and her husband. A jury found her innocent of the charges for 1970 and 1971 but convicted her under 26 U.S.C.A. § 7201 for knowingly misstating her income on her 1972 tax return. She was sentenced to 18 months imprisonment — all but 60 days of which was suspended— placed on probation for 21 months, and fined $5,000 exclusive of any civil tax liability. The taxability of the money received by Garber presents a unique legal question. Because of trial errors which deprived defendant of her defense on the element of willfulness, we reverse the conviction.

Some time in the late 1960’s after the birth of her third child, Dorothy Garber was told that her blood contained a rare antibody useful in the production of blood group typing serum. Dade Reagents, Inc. (Dade Reagents), a manufacturer of diagnostic reagents used in clinical laboratories and blood banks, had made the discovery and in 1967 induced her to enter into a contract for the sale of her blood plasma. By a technique called plasmapheresis, a pint of whole blood was extracted from her arm, plasma was centrifugally separated, and the red cells were returned to her body. The process was then repeated. The two bleeds [94]*94produced one pint of plasma from two pints of blood, and took a total of from one and a half to two and a half hours.

Plasmapheresis is often preceded by a stimulation of the donor whereby the titre or concentration of the desired antibody in the blood is artifically increased by an injection of an incompatible blood type. Both stimulation and plasmapheresis are accompanied by pain and discomfort and carry the risks of hepatitis and blood clotting.

In exchange for Garber’s blood plasma, Dade Reagents agreed to pay her for each bleed on a sliding scale dependent on the titre or strength of the plasma obtained. Dade Reagents then marketed the substance for the production of blood group typing serum.

Because Garber’s blood is so rare — she is one of only two or three known persons in the world with this antibody — she was approached by other laboratories which lured her away from Dade Reagents by offering an increasingly attractive price for her plasma. By 1970, 1971, and 1972, the three years covered in the indictment, she was receiving substantial sums of money in exchange for her plasma.1 For two of those years she was selling her blood under separate contract to Associated Biologicals, Inc. (Associated) and to Biomedical Industries, Inc. (Biomedical), in both cases receiving in exchange a sum of money dependent on the strength of the antibody in each unit sold. In addition, Biomedical offered a weekly salary of $200, provided a leased automobile, and in 1972 added a $25,000 bonus. In that last year Garber sold her plasma to Biomedical exclusively, producing the coveted body fluid as often as six times a month.

For all three years involved, Biomedical had treated the regular $200 weekly payments as a salary subject to withholding taxes and provided Garber with a yearly W-2 form noting the taxes withheld. Every year, Garber attached those W-2 forms to her income tax return (which was filed jointly with her husband whom she has since divorced), declared the $200 per week as income, and paid the taxes due. All other payments, both from Biomedical and from Associated, had been paid directly to defendant by check. No income taxes were withheld by the companies; she received no W-2 forms, and paid no taxes on the money received. Biomedical did, however, file a Form 1099 Information Return with the IRS which showed a portion of Garber’s donor fees not subject to withholding. Garber was provided a copy of each 1099, which plainly states that it is for information only and is not to be attached to the income tax return. She had never before received Information Returns, and, while she was receiving checks from both Biomedical and Associated, only Biomedical provided this information.

In this prosecution for the felony of willful evasion of income taxes the government had the burden of proving every element of the crime beyond a reasonable doubt. Holland v. United States, 348 U.S. 121, 75 S.Ct. 127, 99 L.Ed. 150 (1954); United States v. England, 347 F.2d 425 (7th Cir. 1965). This required proof of a tax deficiency, an affirmative act constituting evasion or attempted evasion of the tax due, and willfulness. Sansone v. United States, 380 U.S. 343, 85 S.Ct. 1004, 13 L.Ed.2d 882 (1965); United States v. Callahan, 588 F.2d 1078 (5th Cir. 1979); United States v. Buckley, 586 F.2d 498 (5th Cir. 1978). The element we find lacking here was willfulness.

At trial, outside the presence of the jury, the government proffered the testimony of Jacquin Bierman, a professor of law and practicing attorney in the City of New York, who stated his opinion that Garber had made available her bodily functions or products for a consideration which constituted taxable gross income. His conclusion was based on section 61(a) of the Internal Revenue Code (Code) which defines gross income as [95]*95all income from whatever source derived, including (but not limited to) the following items:

(1) Compensation for services, including fees, commissions, and similar items;
(3) Gains derived from dealings in property;

26 U.S.C.A. § 61(a). While admitting that this case is the first of its kind, Bierman opined that if the exchanges were considered the sale of a product, there would be no tax basis or original cost for the product sold, and the entire sales price would constitute gain subject to tax under section 61(a)(3). Alternatively, he considered categorizing the transactions as the rendition of a service, in which case he was of the opinion that the entire sales price similarly would be fully taxable under section 61(a)(1).

The defense proffered to the court the testimony of Daniel Nall, a Certified Public Accountant and former revenue agent, who concluded that the money received by Garber was not within the legal definition of income in section 61(a) and that she had therefore participated in tax-free exchanges. He patterned his reasoning on early case law resting on Doyle v. Mitchell Brothers, 247 U.S. 179, 38 S.Ct. 467, 62 L.Ed. 1054 (1918), which held that funds obtained by the conversion of capital assets and which represented only the actual value of such assets was not taxable income. According to Nall, the Attorney General in a 1918 opinion considered the human body a kind of capital asset. Following the reasoning in Doyle, the opinion held that the proceeds of an accident insurance policy were not subject to tax because the proceeds of the insurance policy represented a conversion of the capital loss which the injured taxpayer had suffered. Nall mentioned similar opinions finding settlements received for personal injury not taxable income. Eventually the Code was amended to include a specific provision covering the tax consequences of compensation for injuries or sickness.2

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Dorothy R. Garber, 607 F.2d 92, 44 A.F.T.R.2d (RIA) 6095, 1979 U.S. App. LEXIS 10349 (5th Cir. 1979).

607 F.2d 92 (United States v. Dorothy R. Garber) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Michael Adix
Eleventh Circuit, 2025
United States v. Shah
84 F.4th 190 (Fifth Circuit, 2023)
United States v. Hagen
Fifth Circuit, 2023
United States v. Marletta Jasmine Knowles
889 F.3d 1251 (Eleventh Circuit, 2018)
Perez v. Commissioner
144 T.C. No. 4 (U.S. Tax Court, 2015)
United States v. Michael Vallone
698 F.3d 416 (Seventh Circuit, 2012)
United States v. Ellefsen
655 F.3d 769 (Eighth Circuit, 2011)
United States v. Stein
473 F. Supp. 2d 597 (S.D. New York, 2007)
United States v. Richard Junior Frazier
387 F.3d 1244 (Eleventh Circuit, 2004)
United States v. Jasin
215 F. Supp. 2d 552 (E.D. Pennsylvania, 2002)
Kidder, Peabody & Co. v. IAG International Acceptance Group
14 F. Supp. 2d 391 (S.D. New York, 1998)
G.M. Trading Corp. v. Commissioner
121 F.3d 977 (Fifth Circuit, 1997)
United States v. Paradies
Eleventh Circuit, 1996
United States v. West
Fifth Circuit, 1994
Matter of Humphreys
880 S.W.2d 402 (Texas Supreme Court, 1994)
McKay v. Commissioner
102 T.C. No. 16 (U.S. Tax Court, 1994)
Dover v. Baker, Brown, Sharman & Parker
859 S.W.2d 441 (Court of Appeals of Texas, 1993)